Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · IEX Real-Time Price · USD
5.79
-0.22 (-3.66%)
Jul 22, 2024, 10:19 AM EDT - Market open
Candel Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$11.00
Upside
+89.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +89.98% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +89.98% | May 22, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $9 → $3 | Buy | Maintains | $9 → $3 | -48.19% | May 15, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +20.90% | Mar 31, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +38.17% | Dec 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +89.98% | Dec 2, 2022 |
| BMO Capital | BMO Capital | Buy Maintains $18 → $12 | Buy | Maintains | $18 → $12 | +107.25% | Mar 31, 2022 |
| UBS | UBS | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Aug 23, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Aug 23, 2021 |
| Credit Suisse | Credit Suisse | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 23, 2021 |